Indication
Gastroenteropancreatic Tumors
1 clinical trial
3 products
Clinical trial
Phase I/II Study of Lu-177-DOTATATE (Lutathera) in Combination With Olaparib in Inoperable Gastroenteropancreatico Neuroendocrine Tumors (GEP-NET)Status: Recruiting, Estimated PCD: 2025-07-01
Product
Lu-177-DOTATATEProduct
OlaparibProduct
Amino Acid